BioMedNewsBreaks – Quad M Solutions Inc. (MMMM) Commences Application to Dual List on Upstream

Quad M Solutions (OTC: MMMM), a staffing company providing modern health care solution benefits, today announced that it has begun the application process for dual listing on Upstream, the next-generation trading app for digital securities and NFTs powered by Horizon Fintex (“Horizon”) and MERJ Exchange Limited (“MERJ”). According to the update, the planned dual listing is designed to provide Quad M with the opportunity to access a global, digital-first investor base that can trade using the USDC digital currency along with credit, debit, PayPal, and USD, unlocking liquidity and enhancing price discovery while globalizing the opportunity to invest in OTC-listed Quad M. “The proposed dual listing is an excellent way to reach a worldwide audience of potential investors who will have an opportunity to learn about Quad M’s technology platform, our unique offerings in the health care solution benefits marketplace, and growth potential,” said Joseph Frontiere, CEO of Quad M. “It is also a way to provide greater liquidity and value to our existing and future shareholders.”

To view the full press release, visit https://ibn.fm/RP30K

About Quad M Solutions Inc.

Quad M Solutions is a public holding company that offers self-funded health plans, staffing services, HR-human resources, payroll services, retirement, supplemental and workers compensation insurance to small and mid-sized group employers. The company strives to provide those employers and individuals the right tools to be able to manage and control all the facets in their health care experience and their eventual health outcomes. Prevention, wellness and cures have become part of Quad M’s corporate mission to individuals who want to manage and control their short and long-term health care needs. The company’s self-insured programs are consumer-driven and technology-leveraged and, by itself, self-insurance is affordable, transparent and responsive to the health care and retirement needs of employees who are looking for higher quality benefits, integrated health information and better medical provider access and outcomes. Quad M’s four subsidiaries, NuAxess 2 Inc., PrimeAxess Inc., OpenAxess Inc., and PrimeAxess 2 LLC, are important in conveying who the company is and what it does. For additional information, please visit QuadMSolutions.com and NuAxess.com.

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

BioMedNewsBreaks – Intelligent Bio Solutions Inc. (Nasdaq: INBS) Grows Revenue, Cuts Losses in Fiscal Q3 as Cartridge Sales Drive Margins

Intelligent Bio Solutions (Nasdaq: INBS), a medical technology company delivering rapid, non-invasive testing solutions, reported…

16 hours ago

BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures Orphan Drug Designation Transfer for TPI 287 in Brain Cancer Indications

CNS Pharmaceuticals (NASDAQ: CNSP) announced the successful transfer of Orphan Drug Designation from Cortice Biosciences…

16 hours ago

BioMedNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics to Acquire Kadima Neuropsychiatry Institute

NRx Pharmaceuticals (NASDAQ: NRXP) announced that its wholly owned subsidiary, HOPE Therapeutics(TM), has signed a…

16 hours ago

BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report Q1 2025 Results on May 15 

NRx Pharmaceuticals (NASDAQ: NRXP) announced it will release its first quarter 2025 financial results after…

2 days ago

BioMedNewsBreaks — Calidi Biotherapeutics Inc. (NYSE American: CLDI) Eyes Game-Changing Approach to Cancer Treatment

Calidi Biotherapeutics (NYSE American: CLDI) recently announced promising preclinical results for its innovative RTNova platform, which…

4 days ago

BioMedNewsBreaks — Adageis’ AI-Powered Platform Empowers Smarter Billing, Better Care

Adageis, a healthcare technology company, is transforming how providers manage insurance payments with its AI-driven…

5 days ago